Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Happier then a pig in poop

<< Previous

Bullboard Posts

Next >>

Post by scaleyon Sep 16, 2020 3:26pm

339 Views

Post# 31568770

Happier then a pig in poop

Congrats longs and non bashers. The wait is almost over. Good things are about to happen with R107. Cha Ching. It'll be interesting to see what the bashers have to say in a few weeks, it's always interesting to hear from the bashers. They baught in high , so they bash . Fools. Expect a few outstanding news releases real soon. After that, it's game on. You bashers sold at 4 cents , proves your investment knowledge - zero! It's going up folks , way up, it's obvious.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity